KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Accounts Payables (2016 - 2026)

Pfizer has reported Accounts Payables over the past 18 years, most recently at $4.5 billion for Q1 2026.

  • Quarterly Accounts Payables fell 14.01% to $4.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.5 billion through Mar 2026, down 14.01% year-over-year, with the annual reading at $5.2 billion for FY2025, 6.98% down from the prior year.
  • Accounts Payables was $4.5 billion for Q1 2026 at Pfizer, down from $5.2 billion in the prior quarter.
  • Over five years, Accounts Payables peaked at $6.8 billion in Q4 2022 and troughed at $4.5 billion in Q1 2026.
  • The 5-year median for Accounts Payables is $5.5 billion (2022), against an average of $5.6 billion.
  • Year-over-year, Accounts Payables surged 43.47% in 2022 and then decreased 16.05% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $6.8 billion in 2022, then fell by 1.45% to $6.7 billion in 2023, then decreased by 16.05% to $5.6 billion in 2024, then fell by 6.98% to $5.2 billion in 2025, then decreased by 14.01% to $4.5 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Accounts Payables are $4.5 billion (Q1 2026), $5.2 billion (Q4 2025), and $5.0 billion (Q3 2025).